BlackRock Inc. - DIFFUSION PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
BlackRock Inc. ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$411,000
-18.0%
1,642,7040.0%0.00%
Q4 2021$501,000
-39.9%
1,642,704
+0.4%
0.00%
Q3 2021$834,000
-30.2%
1,636,3340.0%0.00%
Q2 2021$1,195,000
-36.3%
1,636,334
-20.0%
0.00%
Q1 2021$1,876,000
+184.2%
2,044,449
+146.2%
0.00%
Q4 2020$660,000
-5.6%
830,4710.0%0.00%
Q3 2020$699,000
-13.7%
830,4710.0%0.00%
Q2 2020$810,000
+211.5%
830,471
+1.2%
0.00%
Q1 2020$260,000
-31.2%
820,7790.0%0.00%
Q4 2019$378,000820,7790.00%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Yu Fan 89,848$66,0000.75%
Virtu Financial LLC 285,621$209,0000.02%
GSA CAPITAL PARTNERS LLP 30,180$22,0000.00%
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC 43,868$32,0000.00%
Hoover Financial Advisors, Inc. 4,225$3,0000.00%
Renaissance Technologies 1,375,579$1,004,0000.00%
Frontier Wealth Management LLC 25,000$18,0000.00%
UBS Group AG 36,910$27,0000.00%
IFP Advisors, Inc 0$00.00%
OSAIC HOLDINGS, INC. 29,569$22,0000.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders